Aptus Capital Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $169K | Hold |
|
|||||
|
2025
Q1 | $165K | Buy |
|
|||||
|
2024
Q4 | $41.9K | Sell |
|
|||||
|
2024
Q3 | $69.3K | Hold |
|
|||||
|
2024
Q2 | $65K | Sell |
|
|||||
|
2024
Q1 | $72.6K | Buy |
|
|||||
|
2023
Q4 | $68.1K | Sell |
|
|||||
|
2023
Q3 | $130K | Buy |
|
|||||
|
2023
Q2 | $122K | Sell |
|
|||||
|
2023
Q1 | $114K | Buy |
|
|||||
|
2022
Q4 | $57.8K | Hold |
|
|||||
|
2022
Q3 | $55K | Buy |
|
|||||
|
2022
Q2 | $33K | Hold |
|
|||||
|
2022
Q1 | $40K | Buy |
|
|||||
|
2021
Q4 | $41K | Buy |
|